rheumatology
Medicines

Most RA patients will accept biosimilars

Most rheumatology patients would be comfortable taking a biosimilar if it is recommended by their doctor, a Victorian survey shows. Around 75% of 127 patients surveyed at a tertiary RA clinic said they would accept a biosimilar medication if it was recommended by a rheumatologist. The survey, carried out by Dr Tom Kovitwanichkanont and colleagues ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic